Skip to main content

COVID-19 vaccines and cancer

Australia & New Zealand

Haematology Society of Australia and New Zealand
COVID-19 vaccination in haematology patients
Date: 27-Jan-2021
Audience: Medical oncologists and health professionals
Purpose: Guidance on the COVID-19 vaccine for Haematology patients.

Australia and New Zealand Transplant and Cellular Therapies 
Australia and New Zealand Transplant and Cellular Therapies COVID19 Vaccination Consensus Position Statement
Date: 20-Jan-2021
Audience: Medical oncologists and health professionals
Purpose: Guidance on the COVID-19 vaccine for Haematology patients.

UK

British Lymphology Society
Consensus document on COVID-19 vaccination for patients with lymphoedema
Date: 15-Feb-2021
Audience: Medical oncologists and health professionals
Purpose: Consensus recommendations regarding COVID-19 vaccination for patients with lymphoedema:

UK Chemotherapy Board
Clinician Frequently Asked Questions (FAQs) and guidance on COVID-19 vaccine for patients receiving Systemic Anti-Cancer Therapy
Date: 21-Jan-2021
Audience: Medical oncologists and health professionals
Purpose: Guidance on the COVID-19 vaccine for patients receiving systemic anti-cancer therapy.

USA

American Society of Clinical Oncology
COVID-19 Vaccine & Patients with Cancer
Date: 11-Feb-2021
Audience: Medical oncologists and health professionals
Purpose: Q&A on the COVID-19 vaccine and its impact on patients with cancer.

American Society for Radiation Oncology
ASTRO Recommendation on COVID-19 Vaccination for Cancer Patients Receiving Radiation Therapy
Date: 26-Jan-2021
Audience: Radiation oncologists and health professionals
Purpose: Recommendation on the COVID-19 vaccine for cancer patients receiving radiation therapy.

National Comprehensive Cancer Network
Preliminary Recommendations of the NCCN COVID-19 Vaccination Advisory Committee
Date: 25-Jan-2021
Audience: Medical oncologists and health professionals
Purpose: Guidance for COVID-19 vaccinations in people with cancer.

Europe

European Society for Medical Oncology (ESMO)
COVID-19 vaccination in patients with cancer: ESMO releases ten statements
Date: 22-Dec-2020
Audience: Medical oncologists and health professionals
Purpose: Statements on the efficacy and safety of the COVID-19 vaccine in relation to cancer patients.

Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO)
Guideline on evidence-based management of COVID-19 in cancer patients regarding diagnostics, viral shedding, vaccination and therapy
Date: 10-Feb-2021
Audience: Medical oncologists and health professionals
Purpose: Evidence-based recommendations for rapid diagnostics, viral shedding, vaccination and therapy of COVID-19 in cancer patients.